(Q46399292)

21 December 2017

title

Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men. (English)

1 reference

21 December 2017

7

W J Blot

1 reference

21 December 2017

Lisa B Signorello

4

object named as

L B Signorello

1 reference

21 December 2017

author name string

J H Fowke

1

1 reference

21 December 2017

C M Matthews

2

1 reference

21 December 2017

M S Buchowski

3

1 reference

21 December 2017

S S Chang

5

1 reference

21 December 2017

M S Cookson

6

1 reference

21 December 2017

publication date

16 October 2007

1 reference

21 December 2017

Prostate Cancer and Prostatic Diseases

published in

1 reference

21 December 2017

volume

11

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

264-269

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4501022

exact match

0 references

cites work

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Diet, obesity, and risk of fatal prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Are findings from studies of obesity and prostate cancer really in conflict?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Visceral fat accumulation as a risk factor for prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Leptin and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Leptin influences cellular differentiation and progression in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Insulin resistance and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

The metabolic syndrome is associated with reduced risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Obesity and the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Obesity and the risk of prostate cancer (United States)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Leptin in relation to prostate cancer and benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Anthropometrics and Prostate Cancer Risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Diabetes mellitus and risk of prostate cancer (United States).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

A meta-analysis of diabetes mellitus and the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Sex hormones, inflammation and the metabolic syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Waist circumference and testosterone levels in community dwelling men. The Tromsø study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Serum leptin and pathological findings at the time of radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Endogenous sex hormones and metabolic syndrome in aging men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Sex steroid hormones, upper body obesity, and insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Metabolic factors associated with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

The association between body size, prostate volume and prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4501022

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4501022

1 reference

21 December 2017

PubMed ID

17938644

1 reference

21 December 2017